Oncology dietitian Meghan Laszlo explains how pancreatic enzyme replacement drug Creon works and available alternatives.

Psychologist and cancer patient Bill Gardner provides practical tips for living with long-term cancer treatment.

Researchers are testing a new drug that targets KRAS variant G12D in conjunction with different chemotherapies.

Here are some of the most interesting highlights from the 2024 AACR Special Conference on Pancreatic Cancer Research.

Who should be screened for pancreatic cancer? Dr. Allyson Ocean explains how genetic mutations and family history factor into screening.

Dr. Michael Goggins explains who should undergo regular pancreatic cancer screening and where programs can be found.

Get informed about the latest pancreatic cancer screening guidelines for high-risk patients from gasterenterologist Dr. Amitabh Chak.

Who is high-risk for pancreatic cancer? Oncologist Dr. Matthew Yurgelun explains high-risk populations and what steps to take if you meet the criteria.

Because of her early career experience as an oncology nurse, Ann Jaffe wanted to participate in a clinical trial.

When Malcolm Robertson was diagnosed with pancreatic cancer, he already knew he carried the BRCA2 mutation.